Product
CAPEOX
3 clinical trials
6 indications
Indication
Colorectal CancerIndication
CancerIndication
Colorectal cancerIndication
Colon CancerIndication
Neoadjuvant TherapyIndication
ImmunotherapyClinical trial
A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy Versus Standard of Care in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon CancerStatus: Recruiting, Estimated PCD: 2028-12-15
Clinical trial
A Prospective, Single-center, Multi-cohort Study of Envolimab Monotherapy or Envafolimab in Combination With CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer.Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Window of Opportunity Study With Neoadjuvant Pembrolizumab in Colorectal CancerStatus: Recruiting, Estimated PCD: 2024-08-01